Cannabis Bioscience International
(OTC) CBIH
Cannabis Bioscience International Financials at a Glance
Market Cap
$4.65M
Revenue (TTM)
$127.35K
Net Income (TTM)
$592.60K
EPS (TTM)
$-0.00
P/E Ratio
-4.00
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$0.00
Volume
1,006,500
Open
$0.00
Price
$0.00
Volume
1,006,500
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$0.00
Volume
1,006,500
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
CBIH News
CBIH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cannabis Bioscience International
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
2
CEO
Dante Picazo
Website
www.cbih.netHeadquarters
Houston, TX 91789, US
CBIH Financials
Key Financial Metrics (TTM)
Gross Margin
28%
Operating Margin
-3%
Net Income Margin
-5%
Return on Equity
0%
Return on Capital
36%
Return on Assets
-27%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.65M
Shares Outstanding
11.63B
Volume
1.01M
Short Interest
0.00%
Avg. Volume
2.16M
Financials (TTM)
Gross Profit
$262.92K
Operating Income
$421.37K
EBITDA
$335.53K
Operating Cash Flow
$329.63K
Capital Expenditure
$4.00
Free Cash Flow
$329.63K
Cash & ST Invst.
$12.95K
Total Debt
$420.23K
Cannabis Bioscience International Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$53.27K
-28.3%
Gross Profit
$42.77K
-35.6%
Gross Margin
80.29%
N/A
Market Cap
$4.65M
N/A
Market Cap/Employee
$2.33M
N/A
Employees
2
N/A
Net Income
$116.97K
-47.1%
EBITDA
$95.88K
-35.4%
Quarterly Fundamentals
Net Cash
$406.11K
+14.1%
Accounts Receivable
$21.81K
+57.8%
Inventory
$0.00
N/A
Long Term Debt
$249.50K
-23.7%
Short Term Debt
$156.74K
+6.6%
Return on Assets
-26.78%
N/A
Return on Invested Capital
36.14%
N/A
Free Cash Flow
$5.49K
+94.6%
Operating Cash Flow
$5.49K
+94.6%